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Available online 25 May 2016Skin biopsies were collected from three male patients (age 45, 44 and 44) with clinically diagnosed schizophre-
nia. The patientswere diagnosed according to DSM-5 criteria by a trained psychiatrist. Dermal ﬁbroblast cell lines
were established and expanded for subsequent reprogramming procedures. Induced pluripotent stem (iPS) cells
were derived using the integration-free CytoTune®-iPS 2.0 Sendai Reprogramming Kit, containing Sendai virus
particles of the four Yamanaka factors Oct3/4, Sox2, Klf4 and c-Myc.
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Skin ﬁbroblasts were reprogrammed using the CytoTune®-iPS 2.0
Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc, USA), which con-
tains reprogramming vectors with the four Yamanaka factors, Oct3/4,
Sox2, Klf4 and c-Myc. These factors have been repeatedly shown to be
sufﬁcient for efﬁcient reprogramming (Lieu et al., 2013; Takahashi et
al., 2007). The identity of derived human iPS cell lines was conﬁrmed
by immunohistochemistry, using the following antibodies for
pluripotency markers, TRA-1-60, Sox2, Oct3/4 and SSEA4 (Fig. 1A). To
conﬁrm trilineage differentiation potential, in vitro embryonic body
(EB) formation assaywas performed (Fig. 3A). Spontaneous differentia-
tion induced the transcription of the following genes: AFP (endoderm),
MSX1 (mesoderm) and Pax6 (ectoderm) (Fig. 3B). Additionally, the for-
mation of the three germ layers was conﬁrmed at the protein level by
immunocytochemistry, which showed the expression of Nestin, TUJ1,
SMA and AFP (Fig. 3C). Ploidy of the derived iPS cell lines was analyzed
by low-pass whole-genome sequencing (Fig. 2) (Wells et al., 2014).
Materials and methods
Derivation of human ﬁbroblast cell lines EZQ-3, EZQ-4 and EZQ-9
Procedures for sample collection and iPS cell lines generation were
approved by the Institutional Ethics Committee and informed consent
was obtained from the patients and/or their legal tutors. Tissue frag-
ments were collected and cultured as described previously (Chen et
al., 2011) with minor modiﬁcations. Brieﬂy, fresh small skin biopsiesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of three EZQ iPS cell lines. A) Expression of pluripotency markers: TRA-1-60, SOX2, SSEA4 and OCT3/4. Immunoﬂuorescence staining, red/green: pluripotency
markers, Blue: DAPI, nuclei staining. Scale bars, 200 μm. B) Feeder-free EZQ iPS cell lines cultures. C) Reverse transcription PCR for the detection of Sendai transgenes after passage 7.
Transduced cell pool at passage 0 was used as positive control. C–, non-template control.
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1% penicillin-streptomycin (Thermo Fisher Scientiﬁc, USA). Human ﬁ-
broblasts spontaneously migrated after two weeks and were expanded
in standard culture conditions (37 °C in 5% CO2) for 3 passages. The cells
were tested forMycoplasma (MycoAlert™ PLUS, Lonza, USA) before any
further manipulation. Cells at passage 3 were used for iPS cell
generation.
iPS cell lines generation and expansion
Cells were reprogrammed using the integration-free CytoTune®-iPS
2.0 Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc, USA), which
contains Sendai virus particles of the four Yamanaka factors
(Takahashi et al., 2007). Brieﬂy, 3.0–3.5 × 105 human dermal ﬁbroblasts
were plated onto one well of a gelatin-coated 6-well plate 24 h before
virus transduction. The cells were transduced according to the
manufacturer's protocol. Four days after transduction, cells were plated
onto MEF feeder cells, and fed with iPS cells medium supplemented
with 30 ng/mL freshly added bFGF (Thermo Fisher Scientiﬁc, USA).
About 7 days after plating, the ﬁrst appearing colonies were picked for
expansion into individual iPS cell lines and transferred onto Matrigel
(BD Biosciences, USA)-coated plates and cultured with E8 medium
(Thermo Fisher Scientiﬁc, USA). After successful adaptation to feeder-
free conditions of at least 3 iPS colonies from each patient, the cells
were expanded in E8 medium using 0.5 mM EDTA passaging solution
(both from Thermo Fisher Scientiﬁc, USA) (Fig. 1B).
Immunoﬂuorescence staining of iPS cell lines
Oct3/4, Sox2, SSEA4 and Tra-1-60 immunoﬂuorescence staining
conﬁrmed pluripotency genes expression in all EZQ iPS cell lines(Fig. 1A). iPS colonies were plated onto 96-well plates (CellCarrier,
Perkin-Elmer, USA) and ﬁxedwith 4% paraformaldehyde for 20min
at room temperature. Fixed cells were permeabilized with 0.3% Tri-
ton-X and blocked with 2% BSA. Cells were then washed with PBS,
incubated with primary antibodies at 1:100 dilution, at 4 °C, over-
night. Primary antibodies were then washed with PBS and cells
were incubated with secondary antibodies at 1:400 dilutions at
room temperature for 1 h. After washing and incubation with
DAPI for 5 min, cells were covered with glycerol, the plates were
sealed with AlumaSeal CS ﬁlm (Excel Scientiﬁc, USA) and stored
at 4 °C until visualization. Images were acquired using the EVOS
XL Cell Imaging System (Thermo Fisher Scientiﬁc, USA) (Fig. 1A).
The antibodies used in the experiments are listed in Table 2.
In vitro differentiation of iPS cell lines
The differentiation ability of three EZQ iPS cell lines was ana-
lyzed by in vitro embryonic body (EB) formation, as published pre-
viously (Itskovitz-Eldor et al., 2000). Brieﬂy, 100 mm cell culture
dishes with EZQ iPS cell lines were treated with Collagenase IV
(Thermo Fisher Scientiﬁc, USA) for 30–40 min at 37 °C, washed
with PBS and seeded onto 60 mm culture dishes (Corning, USA).
The cultures were maintained on horizontal shaker in DMEM sup-
plemented with 20% KSR, non-essential amino acids, L-glutamine,
penicillin/streptomycin and sodium pyruvate (all from Thermo
Fisher Scientiﬁc, USA) and without bFGF to allow for formation of
embryonic bodies (EBs) (Fig. 3A). After 7 days, EBs were seeded
onto gelatin-coated 100 mm culture dishes and grown for another
21 days with medium change every other day. Subsequently, the
cultures were harvested for total RNA isolation using the GeneJET
RNA Puriﬁcation kit (Thermo Fisher Scientiﬁc, USA), followed by
Fig. 2. Aneuploidy analysis of EZQ iPS cell lines. Analysis of chromosome copy number was carried out using low-pass whole genome sequencing. Snapshot of IGV Light Whole Genome
View screen depicts overviews of the derived iPS cell line chromosome sets. Dots correspond to sequencing tiles approximately 2Mb long each. EZQ-3:MAPD: 0.143; Read count: 318,016;
Total number of bases: 68.29 Mb; Total number of bases (AQ20): 60.49 Mb; % Bases (AQ20): 88.6; Mean coverage depth (fold): 0.022. EZQ-4: MAPD: 0.159; Read count: 251,620; Total
number of bases: 46.53Mb; Total number of bases (AQ20): 39.32Mb; % Bases (AQ20): 84.5; Mean coverage depth (fold): 0.015. EZQ-9: MAPD: 0.135; Read count: 500,276; Total number
of bases: 94.61 Mb; Total number of bases (AQ20): 82.18 Mb; % Bases (AQ20): 86.9; Mean coverage depth(fold): 0.031. MAPD=median absolute pairwise difference.
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Fisher Scientiﬁc, USA). RT-PCR for the three germ layer markers
(Fig. 3B) was carried out using 0.5 μL of the reverse transcription
reaction in a total 10 μL reaction volume, with the following param-
eters: denaturation 95 °C–15 s, Annealing 50 °C–15 s, elongation
72 °C–1 min (35 cycles). The PCR products were analyzed using
agarose gel (1%) electrophoresis. The primers used for PCR are
listed in Table 1. Part of the cultures was also plated onto 96-well
plates (CellCarrier, Perkin-Elmer, USA) to perform immunocyto-
chemistry for the markers of the three germ layers. Immunostain-
ing was performed as described above. Images were acquired
using the Operetta System (Perkin-Elmer, USA) (Fig. 3C).
Virus-free status of iPS cell lines
CytoTune®-iPS 2.0 Reprogramming Kit is considered a non-in-
tegrative system. Nevertheless, it is necessary to conﬁrm whether
the derived iPS cells contain any Sendai virus elements after the
reprogramming procedure. To conﬁrm the absence of Sendai viral
vectors, total RNA was isolated from EZQ iPS cells using the
GeneJET RNA Puriﬁcation Kit (Thermo Fisher Scientiﬁc, USA).
Cells set-aside at the beginning of the reprogramming procedure
(passage 0) were used as positive controls for the presence of Sen-
dai RNA. The reverse transcription reaction was carried out using
300 ng of DNAse-treated RNA and the M-MLV enzyme (Thermo
Fisher Scientiﬁc, USA). The RT-PCR was carried out using 0.5 μL of
the reverse transcription reaction in a total 10 μL reaction volume,with the following parameters: denaturation 95 °C–30 s, annealing
55 °C–30 s, elongation 72 °C–30 s (35 cycles). The PCR products
were analyzed using agarose gel (2%) electrophoresis (Fig. 1C).
The primers used for PCR are listed in Table 1.
Aneuploidy analysis of iPS cell lines
The ploidy of the EZQ iPS cell lines was conﬁrmed by low-pass
whole-genome sequencing (Thermo Fisher Scientiﬁc, USA)
(Fig. 2). Genomic DNA was puriﬁed from approximately 5 × 105
cells using QIAamp DNAMini Kit (Qiagen, USA). The sequencing library
was constructed by the enzymatic fragmentation of 100 ng geno-
mic DNA followed by the ligation of sequencing adaptors using
the Ion Xpress™ Plus Fragment Library Kit (Thermo Fisher Scientif-
ic, USA). Ligated fragments were size selected electrophoretically
using a 2% E-Gel SizeSelect precast agarose gel (Thermo Fisher Sci-
entiﬁc, USA). Adaptor-mediated ampliﬁcation of the library was
subsequently carried out (5 cycles) using the primer mix supplied
with the Ion Xpress™ Plus Fragment Library Kit (Thermo Fisher
Scientiﬁc, USA). The ampliﬁed library was quantitated by real
time PCR using the Ion Library Quantitation Kit, diluted for equali-
zation and 24 pmol were pooled with other libraries for clonal am-
pliﬁcation using the Ion OneTouch system followed by library
enrichment performed on the Ion OneTouch ES (Thermo Fisher Sci-
entiﬁc, USA). Pooled libraries were sequenced using an Ion 316
Chip on the Ion Personal Genome Machine using the 200 bp se-
quencing chemistry Ion PGM™ Hi-Q (Thermo Fisher Scientiﬁc,
Fig. 3. Trilineage differentiation analysis. A) In vitro embryonic body formation assay for pluripotency. B) Conﬁrmation of the expression of germ layermarkers by RT-PCR. Endoderm: AFP;
Mesoderm: MSX1; Ectoderm: Pax6. C) Immunoﬂuorescence staining detection of germ layer markers. Endodermal: AFP, mesodermal: SMA and ectodermal: Nestin and TUJ1. Red/green:
germ layer markers. Blue: DAPI (nuclei). Magniﬁcation, 10×.
100 J. Sochacki et al. / Stem Cell Research 17 (2016) 97–101USA). Aneuploidy analysis was carried using the Low-pass whole-
genome aneuploidy r. 0 workﬂow of the Ion Reporter v.5.0 suite.
In order to ascertain the accuracy of copy number calling ≥ 300,000
300,000 reads/sample, median absolute pairwise difference
(MAPD) ≤ 0.3 and a median coverage depth ≥ 0.2 were set as mini-
mum requirements.Table 1
Reverse transcription-PCR primers.
Target Primer sets
SeV Forward: GGA TCA CTA GGT GAT
Reverse: ACC AGA CAA GAG TTT
KOS Forward: ATG CAC CGC TAC GAC
Reverse: ACC TTG ACA ATC CTG
Klf4 Forward: TTC CTG CAT GCC AGA
Reverse: AAT GTA TCG AAG GTG
c-Myc Forward: TAA CTG ACT AGC AGG
Reverse: TCC ACA TAC AGT CCT G
GAPDH Forward: TTCGACAGTCAGCCGCA
Reverse: GACTCCACGACGTACTC
AFP Forward: AGA GTT GCT AAA GGA
Reverse: AGG CCA ATA GTT TGT
Pax6 Forward: AGA AAG AGT TTG AGA
Reverse: TCA TGT GTG TCT GCA
MSX1 Forward: CCC TGG TGC TGT ACC
Reverse: GGT CCC TTC AAC CTA
a Primer contains SeV genome sequences.
b Annealing of these primers to transgene-speciﬁc target sequences but not to endogenous
CytoTune® 2.0 Sendai reprogramming vectors.Acknowledgements
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Antibodies used for immunocytochemistry.
Antibody Company Catalog number Host Dilution
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TRA-1-60 Merck Millipore MAB4360 Mouse 1:100
SSEA4 Merck Millipore MAB4304 Mouse 1:100
Nestin Sigma Aldrich N5413 Rabbit 1:100
TUJ1 Merck Millipore MAB1637 Mouse 1:100
AFP Santa Cruz Biotechnology SC15375 Rabbit 1:100
SMA Sigma Aldrich A2547 Mouse 1:100
Goat anti-rabbit Alexa Fluor® 488 Thermo Fisher Scientiﬁc A11008 Rabbit 1:400
Goat anti-mouse Alexa Fluor® 594 Thermo Fisher Scientiﬁc A11032 Mouse 1:400
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